Ono Pharmaceutical (OPHLF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2022 | 12-2021 | 09-2021 | 06-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 677,138 | 549,789 | 738,165 | 450,104 | 839,779 |
| Marketable Securities | 371,479 | 420,438 | 439,248 | 388,406 | 85,488 |
| Receivables | 848,063 | 899,334 | 815,324 | 838,492 | 847,334 |
| Inventories | 328,336 | 343,517 | 351,205 | 358,995 | 370,752 |
| Other current assets | 177,439 | 151,395 | 168,704 | 181,408 | 158,304 |
| TOTAL | $2,402,454 | $2,364,472 | $2,512,646 | $2,217,406 | $2,301,658 |
| Non-Current Assets | |||||
| PPE Net | 852,529 | 990,132 | 1,019,655 | 1,030,029 | 1,094,813 |
| Investments And Advances | 1,913,912 | 2,198,064 | 2,532,284 | 2,513,757 | 2,540,486 |
| Intangibles | 486,055 | 618,244 | 652,306 | 666,011 | 666,240 |
| Other Non-Current Assets | 229,283 | 341,581 | 316,499 | 332,941 | 299,107 |
| TOTAL | $3,481,778 | $4,148,021 | $4,520,744 | $4,542,738 | $4,600,646 |
| Total Assets | $5,884,240 | $6,512,501 | $7,033,390 | $6,760,145 | $6,902,313 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 320,759 | 342,329 | 287,160 | 296,078 | 334,714 |
| Other current liabilities | 159,644 | 118,334 | 305,724 | 357,384 | 330,077 |
| TOTAL | $577,585 | $544,702 | $739,075 | $735,917 | $737,184 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 80,296 | 95,066 | 99,627 | 98,180 | 124,570 |
| TOTAL | $88,350 | $104,148 | $109,064 | $108,008 | $134,554 |
| Total Liabilities | $665,927 | $648,850 | $848,138 | $843,934 | $871,747 |
| Shareholders' Equity | |||||
| Common Shares | 133,657 | 152,750 | 157,958 | 157,958 | 166,637 |
| Retained earnings | 4,939,558 | 5,527,351 | 5,620,788 | 5,404,681 | 5,487,283 |
| Other shareholders' equity | 431,574 | 560,917 | 656,795 | 603,951 | 640,344 |
| TOTAL | $5,218,305 | $5,863,651 | $6,185,252 | $5,916,210 | $6,030,576 |
| Total Liabilities And Equity | $5,884,232 | $6,512,501 | $7,033,390 | $6,760,144 | $6,902,323 |